- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 16 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x 1PH: 2-phenyl-N-[3-(3-sulfamoylphenyl)-2H-indazol-5-yl]acetamide(Non-covalent)
1PH.5: 20 residues within 4Å:- Chain A: I.17, G.18, S.19, G.20, S.23, V.25, Q.27, A.37, K.39, I.72, M.88, E.89, C.90, G.91, N.92, L.140, I.149
- Chain C: L.14, K.15
- Ligands: EDO.8
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.17, A:I.17, A:V.25, A:K.39, A:L.140, A:L.140, A:I.149
- Hydrogen bonds: A:Q.27, A:K.39, A:G.91, A:N.92
1PH.20: 20 residues within 4Å:- Chain B: I.17, G.18, S.19, G.20, S.23, V.25, Q.27, A.37, K.39, I.72, M.88, E.89, C.90, G.91, N.92, L.140, I.149
- Chain D: L.14, K.15
- Ligands: EDO.23
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:I.17, B:I.17, B:V.25, B:K.39, B:L.140, B:L.140, B:I.149
- Hydrogen bonds: B:Q.27, B:K.39, B:G.91, B:N.92
1PH.35: 20 residues within 4Å:- Chain A: L.14, K.15
- Chain C: I.17, G.18, S.19, G.20, S.23, V.25, Q.27, A.37, K.39, I.72, M.88, E.89, C.90, G.91, N.92, L.140, I.149
- Ligands: EDO.38
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:I.17, C:I.17, C:V.25, C:K.39, C:L.140, C:L.140, C:I.149
- Hydrogen bonds: C:Q.27, C:K.39, C:G.91, C:N.92
1PH.50: 20 residues within 4Å:- Chain B: L.14, K.15
- Chain D: I.17, G.18, S.19, G.20, S.23, V.25, Q.27, A.37, K.39, I.72, M.88, E.89, C.90, G.91, N.92, L.140, I.149
- Ligands: EDO.53
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:I.17, D:I.17, D:V.25, D:K.39, D:L.140, D:L.140, D:I.149
- Hydrogen bonds: D:Q.27, D:K.39, D:G.91, D:N.92
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 4 residues within 4Å:- Chain A: R.9, Y.11, Y.36, Y.75
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: E.119, H.122, L.272
Ligand excluded by PLIPEDO.8: 8 residues within 4Å:- Chain A: K.39, E.57, L.61, M.86, M.88, I.149
- Ligands: 1PH.5, EDO.10
Ligand excluded by PLIPEDO.9: 1 residues within 4Å:- Chain A: Y.77
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: K.39, Y.54, A.154, Q.156
- Ligands: EDO.8
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: K.115, E.119
- Ligands: EDO.15
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: C.90, N.92, V.142, D.143
- Chain C: S.12, L.14, L.29
Ligand excluded by PLIPEDO.13: 1 residues within 4Å:- Chain A: D.76
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: K.24, Y.40, N.42
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: K.115, V.277, Q.278
- Ligands: EDO.11
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain B: R.9, Y.11, Y.36, Y.75
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain B: E.119, H.122, L.272
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain B: K.39, E.57, L.61, M.86, M.88, I.149
- Ligands: 1PH.20, EDO.25
Ligand excluded by PLIPEDO.24: 1 residues within 4Å:- Chain B: Y.77
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: K.39, Y.54, A.154, Q.156
- Ligands: EDO.23
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain B: K.115, E.119
- Ligands: EDO.30
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain B: C.90, N.92, V.142, D.143
- Chain D: S.12, L.14, L.29
Ligand excluded by PLIPEDO.28: 1 residues within 4Å:- Chain B: D.76
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain B: K.24, Y.40, N.42
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain B: K.115, V.277, Q.278
- Ligands: EDO.26
Ligand excluded by PLIPEDO.36: 4 residues within 4Å:- Chain C: R.9, Y.11, Y.36, Y.75
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain C: E.119, H.122, L.272
Ligand excluded by PLIPEDO.38: 8 residues within 4Å:- Chain C: K.39, E.57, L.61, M.86, M.88, I.149
- Ligands: 1PH.35, EDO.40
Ligand excluded by PLIPEDO.39: 1 residues within 4Å:- Chain C: Y.77
Ligand excluded by PLIPEDO.40: 5 residues within 4Å:- Chain C: K.39, Y.54, A.154, Q.156
- Ligands: EDO.38
Ligand excluded by PLIPEDO.41: 3 residues within 4Å:- Chain C: K.115, E.119
- Ligands: EDO.45
Ligand excluded by PLIPEDO.42: 7 residues within 4Å:- Chain A: S.12, L.14, L.29
- Chain C: C.90, N.92, V.142, D.143
Ligand excluded by PLIPEDO.43: 1 residues within 4Å:- Chain C: D.76
Ligand excluded by PLIPEDO.44: 3 residues within 4Å:- Chain C: K.24, Y.40, N.42
Ligand excluded by PLIPEDO.45: 4 residues within 4Å:- Chain C: K.115, V.277, Q.278
- Ligands: EDO.41
Ligand excluded by PLIPEDO.51: 4 residues within 4Å:- Chain D: R.9, Y.11, Y.36, Y.75
Ligand excluded by PLIPEDO.52: 3 residues within 4Å:- Chain D: E.119, H.122, L.272
Ligand excluded by PLIPEDO.53: 8 residues within 4Å:- Chain D: K.39, E.57, L.61, M.86, M.88, I.149
- Ligands: 1PH.50, EDO.55
Ligand excluded by PLIPEDO.54: 1 residues within 4Å:- Chain D: Y.77
Ligand excluded by PLIPEDO.55: 5 residues within 4Å:- Chain D: K.39, Y.54, A.154, Q.156
- Ligands: EDO.53
Ligand excluded by PLIPEDO.56: 3 residues within 4Å:- Chain D: K.115, E.119
- Ligands: EDO.60
Ligand excluded by PLIPEDO.57: 7 residues within 4Å:- Chain B: S.12, L.14, L.29
- Chain D: C.90, N.92, V.142, D.143
Ligand excluded by PLIPEDO.58: 1 residues within 4Å:- Chain D: D.76
Ligand excluded by PLIPEDO.59: 3 residues within 4Å:- Chain D: K.24, Y.40, N.42
Ligand excluded by PLIPEDO.60: 4 residues within 4Å:- Chain D: K.115, V.277, Q.278
- Ligands: EDO.56
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qiu, W. et al., Crystal Structure of TTK kinase domain with an inhibitor: 400740. To be Published
- Release Date
- 2014-03-26
- Peptides
- Dual specificity protein kinase TTK: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 16 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x 1PH: 2-phenyl-N-[3-(3-sulfamoylphenyl)-2H-indazol-5-yl]acetamide(Non-covalent)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qiu, W. et al., Crystal Structure of TTK kinase domain with an inhibitor: 400740. To be Published
- Release Date
- 2014-03-26
- Peptides
- Dual specificity protein kinase TTK: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A